1. Home
  2. BDSX vs NHIV Comparison

BDSX vs NHIV Comparison

Compare BDSX & NHIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$23.46

Market Cap

276.2M

Sector

Health Care

ML Signal

HOLD

NHIV

NewHold Investment Corp IV Class A Ordinary Shares

N/A

Current Price

$10.05

Market Cap

276.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BDSX
NHIV
Founded
2005
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
276.2M
276.5M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
BDSX
NHIV
Price
$23.46
$10.05
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $39.00
N/A
AVG Volume (30 Days)
★ 93.2K
83.4K
Earning Date
11-02-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $88,499,000.00
N/A
Revenue This Year
$26.51
N/A
Revenue Next Year
$20.25
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 24.08
N/A
52 Week Low
$5.26
$9.96
52 Week High
$31.97
$10.16

Technical Indicators

Market Signals
Indicator
BDSX
NHIV
Relative Strength Index (RSI) 39.96 46.26
Support Level $19.26 N/A
Resistance Level $24.82 $10.16
Average True Range (ATR) 1.88 0.00
MACD -0.55 -0.01
Stochastic Oscillator 18.99 0.00

Price Performance

Historical Comparison
BDSX
NHIV

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About NHIV NewHold Investment Corp IV Class A Ordinary Shares

NewHold Investment Corp IV is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: